FDA 执法报告 D-0173-2027 将 American Health Packaging 氰钴胺注射液 24394A 批次列为二级召回
FDA drug enforcement D-0173-2027: American Health Packaging — Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
FDA 召回执法报告 D-0173-2027 将 American Health Packaging 的氰钴胺注射液 1,000 mcg/mL 批次 24394A 列为二级召回,原因为潜在玻璃颗粒污染。该召回由企业自愿发起,发起日期为 2026 年 10 月 22 日,涉及 4,097 箱、全美分销。报告日期为 2026 年 11 月 11 日,状态 Ongoing 不代表实时召回进展。
记录载明该注射剂批次因潜在玻璃颗粒污染被列为二级召回,并给出批号与全美分销范围,便于核对召回边界。
FDA drug recall enforcement report — D-0173-2027
Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "2550 John Glenn Ave Ste A",
"address_2": "",
"center_classification_date": "20261105",
"city": "Columbus",
"classification": "Class II",
"code_info": "Lot: 24394A, Exp 10-31-2026",
"country": "United States",
"distribution_pattern": "Nationwide in the USA",
"event_id": "100204",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {},
"postal_code": "43217-1188",
"product_description": "Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59",
"product_quantity": "4,097- cartons (25 x 1mL vials)",
"product_type": "Drugs",
"reason_for_recall": "Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.",
"recall_initiation_date": "20261022",
"recall_number": "D-0173-2027",
"recalling_firm": "American Health Packaging",
"report_date": "20261111",
"state": "OH",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov